News & Events
Rationale and design of a home-based mHealth trial to detect asymptomatic AFib
A team of researchers at the Scripps Translational Science Institute (STSI) recently launched the mHealth Screening To Prevent Strokes (mSToPS) study, a clinical trial that uses wearable sensors to detect asymptomatic atrial fibrillation (AFib) in a targeted population. With its strong association with stroke and other thromboembolic events, AFib represents a significant health burden worldwide. Identifying
To truly look inside
Does the iconic symbol of medicine really deliver on its promise to “look inside”? “There is no doubt that the stethoscope will be with us for some time, but with the emergence of more informative handheld ultrasound technologies, the stethoscope’s iconic position could someday be relegated to the historical realm of the doctor’s black bag
Eric Topol: Innovator in Cardiology and Digital Medicine
“I was always curious to understand why poor health seemed to run in my family, so a career in genetics seemed the right direction for me.” – Dr. Eric Topol, Director, Scripps Translational Science Institute The medical journal The Lancet has published a profile of renowned cardiologist Dr. Eric Topol, Director of the Scripps Translational
Researchers identify molecular markers of kidney transplant rejection
Researchers from the Scripps Research Institute (TSRI) and the Scripps Translational Science Institute (STSI) have published a study that shows that genome-wide molecular profiling of kidney biopsies may be a key to catching organ rejection before it’s too late. As outlined in a press release by TSRI, the research demonstrates that acute and chronic kidney
Lessons From La Jolla – Future of Genomic Medicine 2016
The recent Future of Genomic Medicine conference, hosted annually in La Jolla, CA, provided several key takeaways for the audience of physicians, academics and industry leaders, all of whom are interested in using the power of genomics to improve human health. Forbes contributor David Shaywitz outlines his top takeaways in an article summarizing the event:
Patient-Researchers and Physician-Consultants Confront Chronic Disease
In a personal account about what it’s like to live with Type 1 Diabetes, STSI’s Chief Advocate for Participatory Research, Anna McCollister-Slipp, describes the demands of managing her health and disease, and the changing nature of the doctor–patient relationship. “Because of the demands of managing insulin, the role of my physicians has changed dramatically. Once,
San Diego Scientists Solve Mystery Behind A Son’s Sudden Death
In an interview with KPBS, Dardie Robinson, a paralegal from Portland Oregon discusses how researchers at the Scripps Translational Science Institute (STSI) helped solve the medical mystery behind her son Daniel’s sudden death. In a unique collaboration, STSI has partnered with the San Diego County Medical Examiner’s Office to perform ‘molecular autopsies’ using genetic sequencing
Dr. Topol ranked among Most Influential Physicians in History
The online medical resource Medscape has ranked Dr. Eric Topol, Director of the Scripps Translational Science Institute (STSI), among the 50 Most Influential Physicians in History. Medscape editors and advisors sought to identify “the giants of medicine” – physicians who stand apart due to “the extend of their achievements and their impact on the development
Prospective randomized digital medicine trial focuses on health care utilization
Researchers at STSI share findings from mHealth trial targeting hypertension, diabetes, and cardiac arrhythmia. Chronic diseases, such as hypertension, diabetes, and heart arrhythmia, are the leading causes of death and disability in the United States. According to the Centers for Disease Control and Prevention, the treatment of chronic diseases accounts for 86% of the
STSI’s Paul DePodesta to apply analytics expertise to NFL
Paul DePodesta, a renowned baseball executive who joined the Scripps Translational Science Institute (STSI) faculty as Assistant Professor of Bioinformatics at the end of 2015, has been named Chief Strategy Officer with the Cleveland Browns. DePodesta has been instrumental in revolutionizing baseball by applying innovative multi-layered data analysis to player evaluation and recruitment, an approach